POMPANO BEACH, Fla., July 26, 2007 (PRIME NEWSWIRE) -- MEDirect Latino, Inc. (Pink Sheets:MLTO) (www.medirectlatino.org), the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community, announced today that by demonstrating compliance with The Joint Commission's national standards for health care quality and safety, MEDirect Latino, Inc. has earned The Joint Commission's Gold Seal of Approval.
Founded in 1951, The Joint Commission is dedicated to continuously improving the safety and quality of the nation's health care through voluntary accreditation. MEDirect Latino, Inc., which provides diabetic testing supplies and medical products focused exclusively on chronic diseases afflicting the Hispanic community, received the accreditation award after The Joint Commission found that it had demonstrated compliance with The Joint Commission's national standards for home care organizations. The on-site survey occurred in July.
"In becoming accredited, MEDirect Latino, Inc. was evaluated against a set of national standards by a Joint Commission surveyor experienced in the delivery of home care services," says Gina Val Zimmermann, senior executive director, Business Development, The Joint Commission. "Achieving accreditation demonstrates MEDirect Latino's commitment to provide high quality and safe care to its patients."
CEO, Charles W. Hansen III, commented, "Joint Commission accreditation demonstrates that MEDirect Latino is committed to maintaining the highest standards in patient care. Accreditation is an important milestone for the company as we look to expand our business to serve increasing numbers of Medicare-eligible customers. As well, this Joint Commission accreditation is a symbol of excellence to all of our customers and partners that MEDirect is committed to excellence."
Mr. Hansen added, "Accreditation is attainable only through the cooperation and communication among all employees. Every individual at MEDirect Latino, Inc. plays a valuable role in working to meet the Joint Commission's national standards. Knowing that we hold ourselves to a higher standard gives each employee a sense of pride and accomplishment."
ABOUT MEDIRECT LATINO:
MEDirect Latino, Inc. (www.medirectlatino.org) is the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community. MEDirect Latino is rapidly growing and uniquely positioned to service the Hispanic community in the United States and Puerto Rico. MEDirect is the only company currently positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. Type II diabetes was targeted because of its unique status within the Medicare reimbursement regime and due to its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These and other conditions represent considerable future market potential. MEDirect will scale its model by leveraging its existing client base and infrastructure in introducing new products and services to existing customers as they are identified.
The MEDirect Latino Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=1873
Safe Harbor Disclosure: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.